Role of CA1 GABAA and GABAB receptors on learning deficit induced by D-AP5 in passive avoidance step-through task
•Intra-CA1 microinjection of muscimol, baclofen or D-AP5 impaired memory acquisition.•Intra-CA1 injection of bicuculline or phaclofen did not alter memory acquisition.•Muscimol but not bicuculline potentiated D-AP5 response on memory impairment.•Baclofen or phaclofen increased D-AP5 response on memo...
Gespeichert in:
Veröffentlicht in: | Brain research 2018-01, Vol.1678, p.164-173 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Intra-CA1 microinjection of muscimol, baclofen or D-AP5 impaired memory acquisition.•Intra-CA1 injection of bicuculline or phaclofen did not alter memory acquisition.•Muscimol but not bicuculline potentiated D-AP5 response on memory impairment.•Baclofen or phaclofen increased D-AP5 response on memory deficit at the lower doses.•Baclofen or phaclofen reversed D-AP5 response on memory deficit at the higher dose.
To investigate the interaction between hippocampal γ-aminobutyric acid GABAA receptor (GABAAR) or GABAB receptor (GABABR) and N-methyl-D-aspartate receptor (NMDAR) in the acquisition of passive avoidance memory in rats, we used GABAA or GABAB agents, D-AP5 (as a NMDAR antagonist), and a combination of the mentioned drugs in a step-through task. All agents were microinjected into the intra-CA1 regions at a volume of 1 µl/rat, prior to training. GABAAR agonist muscimol (0.2 µg/rat), selective GABABR agonist baclofen (0.5 µg/rat) or NMDAR antagonist D-AP5 (0.25 µg/rat) decreased step-through latency, indicating a memory retention impairment. Neither GABAAR antagonist bicuculline (0.0625–0.25 µg/rat) nor GABABR antagonist phaclofen (0.1–0.5 µg/rat) altered memory retrieval by itself. Moreover, the lower dose of muscimol (0.05 µg/rat) decreased D-AP5 (0.125 µg/rat) response on memory acquisition, but bicuculline did not alter the D-AP5 response. Furthermore, baclofen and phaclofen at the dose of 0.1 µg/rat potentiated D-AP5 response at the doses of 0.0625 and 0.125 µg/rat, but abolished memory impairment induced by D-AP5 at the higher dose (0.25 µg/rat). The results suggest that the microinjection of GABAA and GABAB agents into the CA1 region differently affects memory acquisition deficit induced by D-AP5. The activation of GABAARs increased the impairment effect of D-AP5 on passive avoidance memory, but their blockade did not have an effect. Also, the activation or blockade of GABABRs induced a similar and dual effect. |
---|---|
ISSN: | 0006-8993 1872-6240 |
DOI: | 10.1016/j.brainres.2017.10.004 |